Catherine M. Szyman is SrVP & Pres Diabetes at MEDTRONIC INC (MDT). They have made 3 open-market trades across 1 company since 2008, most recently 2014-04-17.
CIK 0001438538
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MDT | 28,562 | $3.0M |
Shares reported on the most recent Form 4, priced at the 2014-04-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDT | SELL · 10b5-1 | 2014-04-17 | 2014-04-21 | $58.79 | $1.7M | -1.6% | -0.1% | -0.1% |
| MDT | SELL · 10b5-1 | 2014-03-20 | 2014-03-21 | $59.57 | $892K | -1.6% | -0.1% | -0.1% |
| MDT | SELL | 2013-08-26 | 2013-08-28 | $52.60 | $3.0M | -1.6% | -0.1% | -0.1% |
| MDT | SELL | 2009-05-22 | 2009-05-27 | $32.15 | $124K | -1.6% | -0.1% | -0.1% |
| MDT | SELL | 2008-07-10 | 2008-07-14 | $52.66 | $939K | -1.6% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.